{"id":58466,"date":"2024-09-06T12:31:13","date_gmt":"2024-09-06T15:31:13","guid":{"rendered":"https:\/\/insurancecorp.com.br\/pt\/?p=58466"},"modified":"2024-09-06T12:31:13","modified_gmt":"2024-09-06T15:31:13","slug":"ans-promove-audiencia-publica-47","status":"publish","type":"post","link":"https:\/\/insurancecorp.com.br\/pt\/2024\/09\/06\/ans-promove-audiencia-publica-47\/","title":{"rendered":"ANS promove Audi\u00eancia P\u00fablica 47"},"content":{"rendered":"<p>A Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) vai realizar, em 12\/9, a\u00a0<a href=\"https:\/\/www.gov.br\/ans\/pt-br\/acesso-a-informacao\/participacao-da-sociedade\/audiencias-publicas\/audiencia-publica-47\">Audi\u00eancia P\u00fablica 47<\/a>\u00a0para debater a proposta de incorpora\u00e7\u00e3o ao Rol de Procedimentos e Eventos em Sa\u00fade das seguintes tecnologias:<\/p>\n<p>&#8211; Cloridrato de tepotinibe monoidratado, para o tratamento do c\u00e2ncer de pulm\u00e3o de c\u00e9lulas n\u00e3o pequenas (CPNPC) avan\u00e7ado com muta\u00e7\u00f5es do tipo skipping no \u00e9xon 14 do gene MET em pacientes sem tratamento pr\u00e9vio;<\/p>\n<p>&#8211; Cloridrato de asciminibe, para o tratamento de pacientes adultos com leucemia mieloide cr\u00f4nica cromossomo Philadelphia positivo, em fase cr\u00f4nica, previamente tratados com dois ou mais inibidores da tirosina quinase; e<\/p>\n<p>&#8211; Lenalidomida em combina\u00e7\u00e3o com Tafasitamabe, seguida de monoterapia com Tafasitamabe, para o tratamento de pacientes adultos com linfoma difuso de grandes c\u00e9lulas B (LDGCB) recidivante ou refrat\u00e1rio.<\/p>\n<p>As propostas tiveram recomenda\u00e7\u00e3o preliminar de n\u00e3o incorpora\u00e7\u00e3o \u00e0 lista de coberturas obrigat\u00f3rias pelos planos de sa\u00fade, tendo sido debatidas na 32\u00aa reuni\u00e3o?t\u00e9cnica da Comiss\u00e3o de Atualiza\u00e7\u00e3o do Rol de Procedimentos e Eventos em Sa\u00fade?(Cosa\u00fade), realizada em agosto. Elas tamb\u00e9m foram discutidas durante a 611\u00aa Reuni\u00e3o Extraordin\u00e1ria da Diretoria Colegiada (DICOL), realizada no dia 2\/9, na qual foi aprovada a realiza\u00e7\u00e3o da audi\u00eancia p\u00fablica.<\/p>\n<p>As tecnologias tamb\u00e9m est\u00e3o recebendo contribui\u00e7\u00f5es atrav\u00e9s da\u00a0<a href=\"https:\/\/www.gov.br\/ans\/pt-br\/acesso-a-informacao\/participacao-da-sociedade\/consultas-publicas\/consulta-publica-135\">Consulta P\u00fablica 135<\/a>\u00a0at\u00e9 24\/9.\u00a0<a href=\"https:\/\/www.gov.br\/ans\/pt-br\/assuntos\/noticias\/sociedade\/consulta-publica-135-ans-recebe-contribuicoes-para-atualizacao-do-rol\">Clique aqui<\/a>\u00a0para saber mais.<\/p>\n<p>O evento vai ocorrer de forma remota, pela plataforma Teams, com transmiss\u00e3o pelo\u00a0<a href=\"https:\/\/www.youtube.com\/live\/tfALglqemwE\">YouTube<\/a>, das 9h \u00e0s 13h.<\/p>\n<p>Para participar da\u00a0<a href=\"https:\/\/www.gov.br\/ans\/pt-br\/acesso-a-informacao\/participacao-da-sociedade\/audiencias-publicas\/audiencia-publica-47\">Audi\u00eancia P\u00fablica 47<\/a>, \u00e9 preciso fazer inscri\u00e7\u00e3o at\u00e9 as 17h do dia 11\/9,\u00a0<a href=\"https:\/\/www.ans.gov.br\/sisge\/cadastro\/default_sisge.asp?id=616\">clicando aqui<\/a>. A grava\u00e7\u00e3o ficar\u00e1 dispon\u00edvel no site da Ag\u00eancia.<\/p>\n<p><a href=\"https:\/\/www.gov.br\/ans\/pt-br\/acesso-a-informacao\/participacao-da-sociedade\/audiencias-publicas\/audiencia-publica-47\">Clique aqui<\/a>\u00a0para conferir todos os documentos referentes a esta audi\u00eancia p\u00fablica, ou acesse o Portal da ANS e, no menu Acesso \u00e0 Informa\u00e7\u00e3o, entre na se\u00e7\u00e3o Participa\u00e7\u00e3o da Sociedade, item Audi\u00eancias P\u00fablicas.<\/p>\n<p><strong>Assessoria de Imprensa \u2013 ANS<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) vai realizar, em 12\/9, a\u00a0Audi\u00eancia P\u00fablica 47\u00a0para debater a proposta de incorpora\u00e7\u00e3o ao Rol de Procedimentos e Eventos em Sa\u00fade das seguintes tecnologias: &#8211; Cloridrato de tepotinibe monoidratado, para o tratamento do c\u00e2ncer de pulm\u00e3o de c\u00e9lulas n\u00e3o pequenas (CPNPC) avan\u00e7ado com muta\u00e7\u00f5es do tipo skipping no \u00e9xon [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[380],"tags":[779,11944,3509],"jetpack_featured_media_url":"","yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v14.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ANS promove Audi\u00eancia P\u00fablica 47 | Revista Insurance Corp | PT-BR<\/title>\n<meta name=\"robots\" content=\"index, follow\" \/>\n<meta name=\"googlebot\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta name=\"bingbot\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/insurancecorp.com.br\/pt\/2024\/09\/06\/ans-promove-audiencia-publica-47\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANS promove Audi\u00eancia P\u00fablica 47 | Revista Insurance Corp | PT-BR\" \/>\n<meta property=\"og:description\" content=\"A Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) vai realizar, em 12\/9, a\u00a0Audi\u00eancia P\u00fablica 47\u00a0para debater a proposta de incorpora\u00e7\u00e3o ao Rol de Procedimentos e Eventos em Sa\u00fade das seguintes tecnologias: &#8211; Cloridrato de tepotinibe monoidratado, para o tratamento do c\u00e2ncer de pulm\u00e3o de c\u00e9lulas n\u00e3o pequenas (CPNPC) avan\u00e7ado com muta\u00e7\u00f5es do tipo skipping no \u00e9xon [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/insurancecorp.com.br\/pt\/2024\/09\/06\/ans-promove-audiencia-publica-47\/\" \/>\n<meta property=\"og:site_name\" content=\"Revista Insurance Corp | PT-BR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RevistaInsuranceCorp\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-06T15:31:13+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#organization\",\"name\":\"Revista Insurance Corp\",\"url\":\"https:\/\/insurancecorp.com.br\/pt\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/RevistaInsuranceCorp\/\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#logo\",\"inLanguage\":\"pt-BR\",\"url\":\"\",\"caption\":\"Revista Insurance Corp\"},\"image\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#website\",\"url\":\"https:\/\/insurancecorp.com.br\/pt\/\",\"name\":\"Revista Insurance Corp | PT-BR\",\"description\":\"A \\u00fanica revista bil\\u00edngue voltada ao mercado de seguro.\",\"publisher\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/insurancecorp.com.br\/pt\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/2024\/09\/06\/ans-promove-audiencia-publica-47\/#webpage\",\"url\":\"https:\/\/insurancecorp.com.br\/pt\/2024\/09\/06\/ans-promove-audiencia-publica-47\/\",\"name\":\"ANS promove Audi\\u00eancia P\\u00fablica 47 | Revista Insurance Corp | PT-BR\",\"isPartOf\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#website\"},\"datePublished\":\"2024-09-06T15:31:13+00:00\",\"dateModified\":\"2024-09-06T15:31:13+00:00\",\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/insurancecorp.com.br\/pt\/2024\/09\/06\/ans-promove-audiencia-publica-47\/\"]}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/2024\/09\/06\/ans-promove-audiencia-publica-47\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/2024\/09\/06\/ans-promove-audiencia-publica-47\/#webpage\"},\"author\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/person\/1b69c8cf325f0b7167f1b171f52df4af\"},\"headline\":\"ANS promove Audi\\u00eancia P\\u00fablica 47\",\"datePublished\":\"2024-09-06T15:31:13+00:00\",\"dateModified\":\"2024-09-06T15:31:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/2024\/09\/06\/ans-promove-audiencia-publica-47\/#webpage\"},\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#organization\"},\"keywords\":\"ans,Audi\\u00eancia P\\u00fablica 47,promove\",\"articleSection\":\"ANS\",\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/insurancecorp.com.br\/pt\/2024\/09\/06\/ans-promove-audiencia-publica-47\/#respond\"]}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/person\/1b69c8cf325f0b7167f1b171f52df4af\",\"name\":\"Publica\\u00e7\\u00e3o\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#personlogo\",\"inLanguage\":\"pt-BR\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/17226f1f60486eb25d4c6b301ffed37f?s=96&d=mm&r=g\",\"caption\":\"Publica\\u00e7\\u00e3o\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/58466"}],"collection":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/comments?post=58466"}],"version-history":[{"count":1,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/58466\/revisions"}],"predecessor-version":[{"id":58467,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/58466\/revisions\/58467"}],"wp:attachment":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/media?parent=58466"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/categories?post=58466"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/tags?post=58466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}